Differences in pulse pressure day variability between the brachial artery and the aorta in healthy subjects

Artery Research

Volumn 6, Issue 1, 2012, Pages 34-40

  Protogerou, Athanase D ^a   Papaioannou, Theodore G ^a   Sfikakis, Petros P ^a   Blacher, Jacques ^b   Karatzis, Emmanouil ^a   Lekakis, John P ^a   Papadogiannis, Dimitris ^a   Stefanadis, Christodoulos ^a   Safar, Michel E ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Aortic blood pressure; Arterial dependent variability; Augmentation index; Pulse pressure; Pulse pressure amplification; Time dependent variability; Variability

Indexed keywords

ADULT; AORTA; ARTICLE; BLOOD PRESSURE VARIABILITY; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HOME; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULSE PRESSURE; RISK FACTOR; TIME;

EID: 84857058867     PISSN: 18729312     EISSN: 18764401     Source Type: Journal    
DOI: 10.1016/j.artres.2011.11.001     Document Type: Article

References (37)

1. Parati G., Pomidossi G., Albini F., Malaspina D., Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 1987, 5:93-98.
2. Sander D., Kukla C., Klingelhofer J., Winbeck K., Conrad B. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: a 3-year follow-up study. Circulation 2000, 102:1536-1541.
3. Sega R., Corrao G., Bombelli M., Beltrame L., Facchetti R., Grassi G., et al. Blood pressure variability and organ damage in a general population: results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). Hypertension 2002, 39:710-714.
4. Sokolow M., Werdegar D., Kain H.K., Hinman A.T. Relationship between level of blood pressure measured casually and by portable recorders and severity of complications in essential hypertension. Circulation 1966, 34:279-298.
5. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al. ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC Task Force on the management of arterial hypertension. J Hypertens 2007, 25:1751-1762.
6. Stolarz-Skrzypek K., Thijs L., Richart T., Li Y., Hansen T.W., Boggia J., et al. Blood pressure variability in relation to outcome in the international database of ambulatory blood pressure in relation to cardiovascular outcome. Hypertens Res 2010, 33:757-766.
7. Rothwell P.M. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010, 375:938-948.
8. Rothwell P.M., Howard S.C., Dolan E., O'Brien E., Dobson J.E., Dahlof B., et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010, 375:895-905.
9. Avolio A.P., Van Bortel L.M., Boutouyrie P., Cockcroft J.R., McEniery C.M., Protogerou A.D., et al. Role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data. Hypertension 2009, 54:375-383.
10. McEniery C.M., Yasmin, McDonnell B., Munnery M., Wallace S.M., Rowe C.V., et al. Central pressure: variability and impact of cardiovascular risk factors: the Anglo-Cardiff collaborative trial II. Hypertension 2008, 51:1476-1482.
11. Segers P., Mahieu D., Kips J., Rietzschel E., De Buyzere M., De Bacquer D., et al. Amplification of the pressure pulse in the upper limb in healthy, middle-aged men and women. Hypertension 2009, 54:414-420.
12. Protogerou A.D., Papaioannou T.G., Blacher J., Papamichael C.M., Lekakis J.P., Safar M.E. Central blood pressures: do we need them in the management of cardiovascular disease? Is it a feasible therapeutic target?. J Hypertens 2007, 25:265-272.
13. Vlachopoulos C., Aznaouridis K., O'Rourke M.F., Safar M.E., Baou K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 2010, 31:1865-1871.
14. Protogerou A.D., Stergiou G.S., Vlachopoulos C., Blacher J., Achimastos A. The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part II: evidence for specific class-effects of antihypertensive drugs on pressure amplification. Curr Pharm Des 2009, 15:272-289.
15. Williams B., Lacy P.S., Thom S.M., Cruickshank K., Stanton A., Collier D., et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006, 113:1213-1225.
16. Benetos A., Thomas F., Joly L., Blacher J., Pannier B., Labat C., et al. Pulse pressure amplification a mechanical biomarker of cardiovascular risk. J Am Coll Cardiol 2010, 55:1032-1037.
17. Safar M.E., Blacher J., Pannier B., Guerin A.P., Marchais S.J., Guyonvarc'h P.M., et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002, 39:735-738.
18. Papaioannou T.G., Protogerou A.D., Stefanadis C. What to anticipate from pulse pressure amplification. J Am Coll Cardiol 2010, 55:1038-1040.
19. Papaioannou T.G., Karatzis E.N., Papamichael C.M., Karatzi K.N., Zakopoulos N.A., Lekakis J.P., et al. Circadian variation of arterial pressure wave reflections. Am J Hypertens 2006, 19:259-263.
20. Coleman A., Freeman P., Steel S., Shennan A. Validation of the Omron 705IT (HEM-759-E) oscillometric blood pressure monitoring device according to the British Hypertension Society protocol. Blood Press Monit 2006, 11:27-32.
21. O'Brien E., Petrie J., Littler W., de Swiet M., Padfield P.L., O'Malley K., et al. The British Hypertension Society protocol for the evaluation of automated and semi-automated blood pressure measuring devices with special reference to ambulatory systems. J Hypertens 1990, 8:607-619.
22. Pauca A.L., O'Rourke M.F., Kon N.D. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 2001, 38:932-937.
23. Zakopoulos N.A., Tsivgoulis G., Barlas G., Papamichael C., Spengos K., Manios E., et al. Time rate of blood pressure variation is associated with increased common carotid artery intima-media thickness. Hypertension 2005, 45:505-512.
24. Cheng H.M., Wang K.L., Chen Y.H., Lin S.J., Chen L.C., Sung S.H., et al. Estimation of central systolic blood pressure using an oscillometric blood pressure monitor. Hypertens Res 2010, 33:592-599.
25. Papaioannou T.G., Lekakis J.P., Karatzis E.N., Papamichael C.M., Stamatelopoulos K.S., Protogerou A.D., et al. Transmission of calibration errors (input) by generalized transfer functions to the aortic pressures (output) at different hemodynamic states. Int J Cardiol 2006, 110:46-52.
26. Safar M.E., Blacher J., Protogerou A., Achimastos A. Arterial stiffness and central hemodynamics in treated hypertensive subjects according to brachial blood pressure classification. J Hypertens 2008, 26:130-137.
27. Wassertheurer S., Kropf J., Weber T., van der Giet M., Baulmann J., Ammer M., et al. A new oscillometric method for pulse wave analysis: comparison with a common tonometric method. J Hum Hypertens 2010, 24:498-504.
28. Wilkinson I.B., McEniery C.M., Cockcroft J.R. Central blood pressure estimation for the masses moves a step closer. J Hum Hypertens 2010, 24:495-497.
29. Muller J.E., Stone P.H., Turi Z.G., Rutherford J.D., Czeisler C.A., Parker C., et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985, 313:1315-1322.
30. Li Y., Thijs L., Hansen T.W., Kikuya M., Boggia J., Richart T., et al. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension 2010, 55:1040-1048.
31. Wilkinson I.B., Franklin S.S., Hall I.R., Tyrrell S., Cockcroft J.R. Pressure amplification explains why pulse pressure is unrelated to risk in young subjects. Hypertension 2001, 38:1461-1466.
32. Dahlof B., Devereux R.B., Kjeldsen S.E., Julius S., Beevers G., de Faire U., et al. Cardiovascular morbidity and mortality in the Losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002, 359:995-1003.
33. Dahlof B., Sever P.S., Poulter N.R., Wedel H., Beevers D.G., Caulfield M., et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005, 366:895-906.
34. Wing L.M., Reid C.M., Ryan P., Beilin L.J., Brown M.A., Jennings G.L., et al. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003, 348:583-592.
35. Yusuf S., Dagenais G., Pogue J., Bosch J., Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000, 342:154-160.
36. Webb A.J., Fischer U., Mehta Z., Rothwell P.M. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet 2010, 375:906-915.
37. Roman M.J., Pickering T.G., Schwartz J.E., Pini R., Devereux R.B. Relation of blood pressure variability to carotid atherosclerosis and carotid artery and left ventricular hypertrophy. Arterioscler Thromb Vasc Biol 2001, 21:1507-1511.